Self-expanding metal stent placement for oesophageal cancer without fluoroscopy is safe and effective

BACKGROUND: Self-expanding metal stents (SEMS) are widely used to palliate patients with oesophageal cancer. Placement is usually done under endoscopic and fluoroscopic guidance. We have developed an exclusively endoscopic technique to deploy these stents. This article documents the technique and periprocedural experience. Patients and methods: All patients who had SEMS placement for oesophageal cancer at Grey's Hospital, Pietermaritzburg, South Africa, over a 5-year period (2007 - 2011) were reviewed. Stenting was performed without radiological guidance using the technique documented in this article. At endoscopy, the oesophageal lesion was identified, dilated over a guidewire if necessary, and a partially covered stent was passed over the wire and positioned and deployed under direct vision. Data were captured from completed procedure forms and included demographics, tumour length, the presence of fistulas, stent size and immediate complications. RESULTS: A total of 480 SEMS were inserted, involving 453 patients, of whom 43 required repeat stenting. There were 185 female patients (40.8%) and 268 male patients (59.2%). The mean age was 60 years (range 38 - 101). There were 432 black patients (95.4%), 15 white patients (3.3%) and 6 Indian patients (1.3%). The reasons for palliative stenting were distributed as follows: age >70 years n=95 patients, tumour >8 cm n=142, tracheo-oesophageal fistula (TOF) n=29, and unspecified n=170. One patient refused surgery, and one stent was placed for a post-oesophagectomy leak. Repeat stenting was for stent migration (n=15), tumour overgrowth (n=26) and a blocked stent and a stricture (n=1 each). Complications were recorded in six cases (1.3%): iatrogenic TOF (n=2), false tracts (n=3) and perforation (n=1). All six were nevertheless successfully stented. There was no periprocedural mortality. CONCLUSION: The endoscopic placement technique described is a viable and safe option with a low periprocedural complication rate. It is of particular use in situations of restricted access to fluoroscopic guidance.

Saved in:
Bibliographic Details
Main Authors: Govender,M, Aldous,C, Ferndale,L, Thomson,S R, Clarke,D L
Format: Digital revista
Language:English
Published: South African Medical Association 2015
Online Access:http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742015001000020
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0256-95742015001000020
record_format ojs
spelling oai:scielo:S0256-957420150010000202015-10-21Self-expanding metal stent placement for oesophageal cancer without fluoroscopy is safe and effectiveGovender,MAldous,CFerndale,LThomson,S RClarke,D LBACKGROUND: Self-expanding metal stents (SEMS) are widely used to palliate patients with oesophageal cancer. Placement is usually done under endoscopic and fluoroscopic guidance. We have developed an exclusively endoscopic technique to deploy these stents. This article documents the technique and periprocedural experience. Patients and methods: All patients who had SEMS placement for oesophageal cancer at Grey's Hospital, Pietermaritzburg, South Africa, over a 5-year period (2007 - 2011) were reviewed. Stenting was performed without radiological guidance using the technique documented in this article. At endoscopy, the oesophageal lesion was identified, dilated over a guidewire if necessary, and a partially covered stent was passed over the wire and positioned and deployed under direct vision. Data were captured from completed procedure forms and included demographics, tumour length, the presence of fistulas, stent size and immediate complications. RESULTS: A total of 480 SEMS were inserted, involving 453 patients, of whom 43 required repeat stenting. There were 185 female patients (40.8%) and 268 male patients (59.2%). The mean age was 60 years (range 38 - 101). There were 432 black patients (95.4%), 15 white patients (3.3%) and 6 Indian patients (1.3%). The reasons for palliative stenting were distributed as follows: age >70 years n=95 patients, tumour >8 cm n=142, tracheo-oesophageal fistula (TOF) n=29, and unspecified n=170. One patient refused surgery, and one stent was placed for a post-oesophagectomy leak. Repeat stenting was for stent migration (n=15), tumour overgrowth (n=26) and a blocked stent and a stricture (n=1 each). Complications were recorded in six cases (1.3%): iatrogenic TOF (n=2), false tracts (n=3) and perforation (n=1). All six were nevertheless successfully stented. There was no periprocedural mortality. CONCLUSION: The endoscopic placement technique described is a viable and safe option with a low periprocedural complication rate. It is of particular use in situations of restricted access to fluoroscopic guidance.South African Medical AssociationSAMJ: South African Medical Journal v.105 n.10 20152015-10-01journal articletext/htmlhttp://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742015001000020en
institution SCIELO
collection OJS
country Sudáfrica
countrycode ZA
component Revista
access En linea
databasecode rev-scielo-za
tag revista
region África del Sur
libraryname SciELO
language English
format Digital
author Govender,M
Aldous,C
Ferndale,L
Thomson,S R
Clarke,D L
spellingShingle Govender,M
Aldous,C
Ferndale,L
Thomson,S R
Clarke,D L
Self-expanding metal stent placement for oesophageal cancer without fluoroscopy is safe and effective
author_facet Govender,M
Aldous,C
Ferndale,L
Thomson,S R
Clarke,D L
author_sort Govender,M
title Self-expanding metal stent placement for oesophageal cancer without fluoroscopy is safe and effective
title_short Self-expanding metal stent placement for oesophageal cancer without fluoroscopy is safe and effective
title_full Self-expanding metal stent placement for oesophageal cancer without fluoroscopy is safe and effective
title_fullStr Self-expanding metal stent placement for oesophageal cancer without fluoroscopy is safe and effective
title_full_unstemmed Self-expanding metal stent placement for oesophageal cancer without fluoroscopy is safe and effective
title_sort self-expanding metal stent placement for oesophageal cancer without fluoroscopy is safe and effective
description BACKGROUND: Self-expanding metal stents (SEMS) are widely used to palliate patients with oesophageal cancer. Placement is usually done under endoscopic and fluoroscopic guidance. We have developed an exclusively endoscopic technique to deploy these stents. This article documents the technique and periprocedural experience. Patients and methods: All patients who had SEMS placement for oesophageal cancer at Grey's Hospital, Pietermaritzburg, South Africa, over a 5-year period (2007 - 2011) were reviewed. Stenting was performed without radiological guidance using the technique documented in this article. At endoscopy, the oesophageal lesion was identified, dilated over a guidewire if necessary, and a partially covered stent was passed over the wire and positioned and deployed under direct vision. Data were captured from completed procedure forms and included demographics, tumour length, the presence of fistulas, stent size and immediate complications. RESULTS: A total of 480 SEMS were inserted, involving 453 patients, of whom 43 required repeat stenting. There were 185 female patients (40.8%) and 268 male patients (59.2%). The mean age was 60 years (range 38 - 101). There were 432 black patients (95.4%), 15 white patients (3.3%) and 6 Indian patients (1.3%). The reasons for palliative stenting were distributed as follows: age >70 years n=95 patients, tumour >8 cm n=142, tracheo-oesophageal fistula (TOF) n=29, and unspecified n=170. One patient refused surgery, and one stent was placed for a post-oesophagectomy leak. Repeat stenting was for stent migration (n=15), tumour overgrowth (n=26) and a blocked stent and a stricture (n=1 each). Complications were recorded in six cases (1.3%): iatrogenic TOF (n=2), false tracts (n=3) and perforation (n=1). All six were nevertheless successfully stented. There was no periprocedural mortality. CONCLUSION: The endoscopic placement technique described is a viable and safe option with a low periprocedural complication rate. It is of particular use in situations of restricted access to fluoroscopic guidance.
publisher South African Medical Association
publishDate 2015
url http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742015001000020
work_keys_str_mv AT govenderm selfexpandingmetalstentplacementforoesophagealcancerwithoutfluoroscopyissafeandeffective
AT aldousc selfexpandingmetalstentplacementforoesophagealcancerwithoutfluoroscopyissafeandeffective
AT ferndalel selfexpandingmetalstentplacementforoesophagealcancerwithoutfluoroscopyissafeandeffective
AT thomsonsr selfexpandingmetalstentplacementforoesophagealcancerwithoutfluoroscopyissafeandeffective
AT clarkedl selfexpandingmetalstentplacementforoesophagealcancerwithoutfluoroscopyissafeandeffective
_version_ 1756005761548288000